日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Results From First-in-Human Phase I Study of a Novel CD19-1XX Chimeric Antigen Receptor With Calibrated Signaling in Large B-Cell Lymphoma

一项针对新型CD19-1XX嵌合抗原受体的I期临床试验结果显示,该受体在大B细胞淋巴瘤中具有可校准的信号传导功能。

Park, Jae H; Palomba, M Lia; Perica, Karlo; Devlin, Sean M; Shah, Gunjan; Dahi, Parastoo B; Lin, Richard J; Salles, Gilles; Scordo, Michael; Nath, Karthik; Valtis, Yannis K; Lynch, Alec; Cathcart, Elizabeth; Zhang, Honglei; Schoder, Heiko; Leithner, Doris; Liotta, Kelly; Yu, Alina; Stocker, Kelsey; Li, Jia; Dey, Agnish; Sellner, Leopold; Singh, Reshma; Sundaresan, Varsha; Tong, Xin; Zhao, Faye; Mansilla-Soto, Jorge; He, Changhao; Meyerson, Joel; Hosszu, Kinga; McAvoy, Devin; Wang, Xiuyan; Rivière, Isabelle; Sadelain, Michel

Phase I Trial of MCARH109, a G Protein-Coupled Receptor Class C Group 5 Member D (GPRC5D)-Targeted Chimeric Antigen Receptor T-Cell Therapy for Multiple Myeloma: An Updated Analysis

MCARH109(一种靶向G蛋白偶联受体C类5成员D (GPRC5D) 的嵌合抗原受体T细胞疗法)治疗多发性骨髓瘤的I期临床试验:最新分析

Jurgens, Eric M; Firestone, Ross S; Chaudhari, Jagrutiben; Hosszu, Kinga; Devlin, Sean M; Shah, Urvi A; Landa, Jonathan; McAvoy, Devin P; Lesokhin, Alexander M; Korde, Neha; Hassoun, Hani; Tan, Carlyn R; Hultcrantz, Malin; Shah, Gunjan L; Landau, Heather J; Chung, David J; Scordo, Michael; Eren, Ozgur Can; Dogan, Ahmet; Giralt, Sergio A; Park, Jae H; Rivière, Isabelle; Brentjens, Renier J; Smith, Eric L; Wang, Xiuyan; Usmani, Saad Z; Mailankody, Sham

Barriers to Chimeric Antigen Receptor T-Cell Therapy

嵌合抗原受体T细胞疗法的障碍

Valtis, Yannis K; Chin, Kuo-Kai; Nemirovsky, David; Devlin, Sean M; Yisraeli Salman, Meira; Boussi, Leora; Cadzin, Briana; McLoughlin, Carina; Cathcart, Elizabeth; Davis, Paul; Brooklyn, Chelsea; Goldstein, Todd; Famulare, Chris; Shah, Gunjan L; Walji, Moneeza; Scordo, Michael; Boardman, Alexander P; Shouval, Roni; Stein, Eytan M; Geyer, Mark B; Mailankody, Sham; Palomba, M Lia; Usmani, Saad Z; Salles, Gilles; Giralt, Sergio A; Perales, Miguel-Angel; Park, Jae H

Patterns and safety of glucocorticosteroid use following CD19 CAR-T therapy for large B-cell lymphoma

CD19 CAR-T疗法治疗大B细胞淋巴瘤后糖皮质激素的使用模式和安全性

Luttwak, Efrat; Nemirovsky, David; Devlin, Sean M; Boardman, Alexander P; Cassanello, Giulio; Corona, Magdalena; Luan, Danny; Dahi, Parastoo B; Abia, Alejandro Luna De; Falchi, Lorenzo; Landego, Ivan; Lin, Richard J; Lue, Jeniffer K; Palomba, Lia M; Park, Jae H; Raj, Sandeep S; Rejeski, Kai; Rivas Delgado, Alfredo; Scordo, Michael; Tomas, Ana Alarcon; Shah, Gunjan L; Perales, Miguel-Angel; Salles, Gilles; Shouval, Roni

CAR T-cell therapy response varies by extranodal disease site in large B-cell lymphoma

CAR-T细胞疗法在大B细胞淋巴瘤中的疗效因结外病变部位而异。

Luna, Alejandro; Devlin, Sean M; Rejeski, Kai; Flynn, Jessica R; Corona, Magdalena; Luttwak, Efrat; Rivas-Delgado, Alfredo; Landego, Ivan; Cassanello, Giulio; Gomez-Llobell, Marina; Raj, Sandeep S; Dahi, Parastoo B; Lin, Richard J; Parascondola, Allison; Palomba, M Lia; Shah, Gunjan L; Scordo, Michael; Alarcon Tomas, Ana; Leithner, Doris; Bedmutha, Akshay; Schöder, Heiko; Imber, Brandon S; Salles, Gilles; Park, Jae H; Perales, Miguel-Angel; Shouval, Roni

Multimodal and Data-Driven Assessment of Myeloid Neoplasms Refines Classification across Disease States

多模态和数据驱动的髓系肿瘤评估可改进疾病状态下的分类

Lachowiez, Curtis A; Asimomitis, Georgios; Bernard, Elsa; Devlin, Sean M; Tazi, Yanis; Creignou, Maria; Germing, Ulrich; Gattermann, Norbert; Gilkes, Amanda; Thomas, Ian; Bullinger, Lars; Döhner, Konstanze; Malcovati, Luca; Othman, Jad; Dillon, Richard; Eisfeld, Ann-Kathrin; Nicolet, Deedra; Issa, Ghayas C; Daver, Naval; Kadia, Tapan M; DiNardo, Courtney D; Ravandi, Farhad; Garcia-Manero, Guillermo; Montalban-Bravo, Guillermo; Russell, Nigel; Cazzola, Mario; Döhner, Hartmut; Huntly, Brian J P; Hasserjian, Robert P; Hellström-Lindberg, Eva; Papaemmanuil, Elli; Loghavi, Sanam

Minimal Residual Disease as an Early Endpoint for Accelerated Drug Approval in Myeloma: A Roadmap

微小残留病灶作为多发性骨髓瘤加速药物审批的早期终点:路线图

Landgren, Ola; Devlin, Sean M

Predictors and implications of renal injury after CD19 chimeric antigen receptor T-cell therapy

CD19嵌合抗原受体T细胞疗法后肾损伤的预测因素和影响

Boardman, Alexander P; Gutgarts, Victoria; Flynn, Jessica; Devlin, Sean M; Goldman, Adam; Tomas, Ana Alarcon; Fein, Joshua A; Slingerland, John B; Parascondola, Allison; Lin, Richard J; Scordo, Michael; Dahi, Parastoo B; Giralt, Sergio; Palomba, M Lia; Salles, Gilles; Nath, Karthik; Walji, Moneeza; Corona, Magdalena; Park, Jae H; Shah, Gunjan L; Perales, Miguel-Angel; Jaffer-Sathick, Insara; Shouval, Roni

Comparative real-world outcomes of CD19-directed CAR T-cell therapies in large B-cell lymphoma

CD19靶向CAR T细胞疗法在大B细胞淋巴瘤中的真实世界疗效比较

Deschênes-Simard, Xavier; Bromberg, Maria; Devlin, Sean M; Gonen, Mithat; Beyar-Katz, Ofrat; Ip, Andrew; Marcus, Ronit; Avigdor, Abraham; Ballweg, Annamaria; Rabinovich, Emma; Alhomoud, Mohammad; Rivas Delgado, Alfredo; Corona De Lapuerta, Magdalena; Luna De Abia, Alejandro; Palomba, Maria Lia; Shah, Gunjan L; Lin, Richard; Boardman, Alexander P; Falchi, Lorenzo; Lue, Jennifer; Salles, Gilles; Perales, Miguel-Angel; Shouval, Roni; Dahi, Parastoo B; Scordo, Michael

Treatment failure patterns in early versus late introduction of CAR T-cell therapy in large B-cell lymphoma

大B细胞淋巴瘤早期与晚期引入CAR-T细胞疗法的治疗失败模式

Corona, Magdalena; Ip, Andrew; Brown, Samantha; Luna, Alejandro; Khatib, Hazim; Flynn, Jessica R; Devlin, Sean M; Landego, Ivan; Cassanello, Giulio; Rejeski, Kai; Zuckerman, Tsila; Dahi, Parastoo B; Scordo, Michael; Lin, Richard J; Kabat, Maciej; Luttwak, Efrat; Pavkovic, Emma; Palomba, M Lia; Park, Jae; Salles, Gilles; Schoder, Heiko; Leithner, Doris; Leslie, Lori A; Perales, Miguel-Angel; Beyar-Katz, Ofrat; Shah, Gunjan L; Shouval, Roni